NOS2 and Alzheimer disease: Moreover, a recent and extensive review of the literature [139] on potential biomarkers in AD reported that while iNOS may be the candidate biomarker for AD diagnosis, other biomarkers may be more reliable to evaluate disease severity and treatment response.